跳至主要内容
临床试验/NCT02885909
NCT02885909招募中4 期

The Effects of Glucose Control and Monitor on Inflammation in the Hospitalized Patients With Hyperglycemia

Taichung Veterans General Hospital2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
600
试验地点
2
主要终点
Glucose target

研究概览

简要总结

This study will be conducted in the ward of Taichung Veterans General Hospital. The patient with hyperglycemia in hospitalization will be enrolled by glucose management team.

详细描述

This study will be conducted in the ward of Taichung Veterans General Hospital. The type 2 diabetic patient with hyperglycemia in hospitalization are candidates. The glucose will be controlled using the insulin protocal based on the glucose monitor systems. We will assess the effects of insulin protocal and glucose monitor system on the inpatient with hyperglycemia.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetic inpatient
  • Fasting glucose >140 mg/dl or random glucose >180 mg/dl

排除标准

  • incooperative for glucose monitor
  • refusal of insulin
  • pregnancy

结局指标

主要结局

Glucose target

时间窗: 6 days

The ratio of glucose less than 180 mg/dl

次要结局

  • Vascular Cell Adhesion Molecule 1 (VCAM-1)(6 days)
  • Brain-Derived Neurotrophic Factor (BDNF)(6 days)
  • Fasting glucose target(6 days)
  • Hypoglycemia(times)
  • Orexin-A(6 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Inpatient Blood Glucose Control in Taichung Veterans... | 临床试验